Electrical remodeling in cardiac hypertrophy

Trends in Cardiovascular Medicine

Volumn 13, Issue 8, 2003, Pages 316-322

  Hill, Joseph A ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; POTASSIUM CHANNEL BLOCKING AGENT; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL BLOCKING AGENT;

ANATOMY; CALCIUM SIGNALING; CALCIUM TRANSPORT; CLINICAL TRIAL; DEVICE; DISEASE ACTIVITY; HEART ARRHYTHMIA; HEART ATRIOVENTRICULAR NODE; HEART DISEASE; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART PACING; HEART REPOLARIZATION; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HUMAN; ION CURRENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SODIUM CALCIUM EXCHANGE;

CALCIUM CHANNELS, L-TYPE; CARDIOMEGALY; ELECTROPHYSIOLOGY; HEART CONDUCTION SYSTEM; HUMANS; SODIUM-CALCIUM EXCHANGER; VENTRICULAR REMODELING;

EID: 0242334046     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2003.08.002     Document Type: Review

References (61)

1. Abraham W.T., Fisher W.G., Smith A.L.et al. Cardiac resynchronization in chronic heart failure. New Engl J Med. 346:2002;1845-1853.
2. Allessie M., Boyden P., Camm A.J.et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 103:2001;769-777.
3. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res. 54:2002;230-246.
4. Antos C.L., McKinsey T.A., Frey N.et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci USA. 99:2002;907-909.
5. Antzelevitch C., Sicouri S., Lukas A.et al. Regional differences in the electrophysiology of ventricular cells. physiological implications Zipes D.P., Jalife J. Cardiac Electrophysiology. From Cell to Bedside:1995;WB Saunders, 228-245, Philadelphia.
6. Armoundas A.A., Wu R., Juang G.et al. Electrical and structural remodeling of the failing ventricle. Pharmacol Ther. 92:2001;213-230.
7. Armoundas A.A., Hobai I.A., Tomaselli G.F.et al. Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ Res. 93:2003;46-53.
8. Bers D.M., Pogwizd S.M., Schlotthauer K. Upregulated Na/Ca exchange is involved in both contractile dysfunction and arrhythmogenesis in heart failure. Basic Res Cardiol. 97:2002;I36-I42.
9. Boateng S.Y., Naqvi R.U., Koban M.U.et al. Low-dose ramipril treatment improves relaxation and calcium cycling after established cardiac hypertrophy. Am J Physiol. 280:2001;H1029-H1038.
10. 2+ exchanger peak near birth in developing rabbit and rat hearts. Circ Res. 74:1994;354-359.
11. Brown D.W., Giles W.R., Croft J.B. Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. Am Heart J. 140:2000;848-856.
12. Brundel B.J.J.M., Henning R.H.et al. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc Res. 54:2002;315-324.
13. Carafoli E., Genazzani A., Guerini D. Calcium controls the transcription of its own transporters and channels in developing neurons. Biochem Biophys Res Commun. 266:1999;624-632.
14. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ Res. 91:2002;517-524.
15. Consensus Committee Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 83:1999;1A-38A.
16. 2+ channel preassociation. Neuron. 39:2003;97-107.
17. 2+ exchanger in failing human myocardium. Circulation. 94:1996;992-1002.
18. Frey N., Olson E.N. Cardiac hypertrophy. the good, the bad and the ugly Annu Rev Physiol. 65:2003;45-79.
19. Frey N., McKinsey T.A., Olson E.N. Decoding calcium signals involved in cardiac growth and function. Nat Med. 6:2000;1221-1227.
20. + current diversity in mouse ventricular myocytes. J Physiol (Lond). 521:1999;587-599.
21. Hart G. Cellular electrophysiology in cardiac hypertrophy and failure. Cardiovasc Res. 28:1994;933-946.
22. Hasenfuss G., Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol. 34:2002;951-969.
23. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation. 99:1999;641-648.
24. Hill J.A., Karimi M., Kutschke W.et al. Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. Circulation. 101:2000;2863-2869.
25. Hill J.A., Rothermel B.A., Yoo K.-D.et al. Targeted inhibition of calcineurin in pressure-overload hypertrophy. Preservation of systolic function J Biol Chem. 277:2002;10,251-10,255.
26. 2+ exchange activity in canine pacing-induced heart failure. Circ Res. 87:2000;690-698.
27. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev. 69:1989;1049-1169.
28. Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res. 87:2000;1095-1102.
29. 2+ exchanger in response to cardiac pressure overload. Am J Physiol. 265:1993;H1024-H1029.
30. Koren M.J., Devereux R.B., Casale P.N.et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Int Med. 114:1991;345-352.
31. Kuo H.-C., Cheng C.-F., Clark R.B.et al. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of Ito and confers susceptibility to ventricular tachycardia. Cell. 801-813:2001.
32. 2+ exchanger Am J Physiol. 276:1999;H1868-H1876.
33. Levy D., Garrison R.J., Savage D.D.et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl J Med. 322:1990;1561-1566.
34. 2+ channels in NG108-15 (rodent neuroblastoma × glioma hybrid) cells. J Physiol. 510:1998;371-385.
35. Marban E. Heart failure. the electrophysiologic connection J Cardiovasc Electrophysiol. 10:1999;1425-1428.
36. q. Am J Physiol. 279:2000;H139-H148.
37. Molkentin J.D., Lu J.-R., Antos C.L.et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 93:1998;215-228.
38. Mukherjee R., Spinale F.G. L-type calcium channel abundance and function with cardiac hypertrophy and failure. a review J Mol Cell Cardiol. 30:1998;1899-1916.
39. Nabauer M., Kaab S. Potassium channel down-regulation in heart failure. Cardiovasc Res. 37:1998;324-334.
40. 2+ channel activity in hippocampal neurons. increased effect with age in culture Neuroscience. 110:2002;213-225.
41. Ozcan C., Jahangir A., Friedman P.A.et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. New Engl J Med. 344:2001;1043-1051.
42. 2+ content in isolated failing and nonfailing human myocardium. Circ Res. 85:1999;38-46.
43. Philipson K.D., Nicoll D.A. Sodium-calcium exchange. a molecular perspective Annu Rev Physiol. 62:2000;111-133.
44. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res. 85:1999;1009-1019.
45. Rusnak F., Mertz P. Calcineurin. form and function Physiol Rev. 80:2000;1483-1521.
46. 2+ exchanger. Circ Res. 87:2000;581-587.
47. Schröder F., Handrock R., Beuckelmann D.J.et al. Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation. 98:1998;969-976.
48. 2+ channels by activation of protein phosphatase type 2B and by direct interaction with the channel. J Gen Physiol. 110:1997;503-513.
49. 2+ release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes. potential link between contractile adaptation and arrhythmogenesis Circulation. 102:2000;2137-2144.
50. 2+ exchanger in end-stage human heart failure. Circ Res. 75:1994;443-453.
51. Tomaselli G.F., Beuckelmann D.J., Calkins H.G.et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation. 90:1994;2534-2539.
52. 2+ channels in GH3 cells. direct evidence against dephosphorylation by calcineurin J Membr Biol. 156:1997;53-61.
53. Vlahos C.J., McDowell S.A., Clerk A. Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov. 2:2003;99-113.
54. 2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heartbeat. J Biol Chem. 275:2000;36,991-36,998.
55. Wang Z., Kutschke W., Richardson K.E.et al. Electrical remodeling in pressure-overload cardiac hypertrophy. role of calcineurin Circulation. 104:2001;1657-1663. a.
56. 2+ exchanger remodeling in pressure-overload cardiac hypertrophy. J Biol Chem. 276:2001;17,706-17,711. b.
57. Wickenden A.D., Kaprielian R., Kassiri Z.et al. The role of action potential prolongation and altered intracellular calcium handling in the pathogenesis of heart failure. Cardiovasc Res. 37:1998;312-323.
58. 2+ homeostasis in rabbits with pacing-induced heart failure. Am J Physiol. 275:1998;H1441-H1448.
59. 2+ channel currents in cardiac hypertrophy induced by activation of calcineurin-dependent pathway. J Mol Cell Cardiol. 33:2001;249-259.
60. Zeilhofer H.U., Blank N.M., Neuhuber W.L.et al. Calcium-dependent inactivation of neuronal calcium channel currents in independent of calcineurin. Neuroscience. 95:2000;235-241.
61. NaCa contributes to electrical heterogeneity within the canine ventricle. Am J Physiol. 278:2000;H1671-H1678.